ROCKWELL MEDICAL, INC. Warrants and Rights Outstanding
ROCKWELL MEDICAL, INC. (RMTI) had Warrants and Rights Outstanding of $4.23 million as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2015-03-03
- 2014-09-30: Warrants and Rights Outstanding $4.23M.
- 2014-06-30: Warrants and Rights Outstanding $4.23M.
- 2014-03-31: Warrants and Rights Outstanding $4.23M.
- 2013-12-31: Warrants and Rights Outstanding $4.90M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2014-09-30 | $4.23M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $4.23M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $4.23M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $4.90M 10-K · filed 2015-03-03 |
| 2013-09-30 | $5.16M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $7.79M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $8.00M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $7.18M 10-K · filed 2014-03-07 |
| 2012-09-30 | $6.90M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $6.90M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $7.13M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $7.10M 10-K · filed 2013-03-18 |
| 2011-09-30 | $7.07M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $7.41M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $8.28M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |